27 min listen
The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma, with Drs. Michael Dickinson and Loretta J. Nastoupil
FromThe Hematologist
The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma, with Drs. Michael Dickinson and Loretta J. Nastoupil
FromThe Hematologist
ratings:
Length:
34 minutes
Released:
Apr 4, 2023
Format:
Podcast episode
Description
In this installment, Contributing Editor Dr. Loretta J. Nastoupil has a conversation with Dr. Michael Dickinson. They discuss the New England Journal of Medicine article covered by Dr. Nastoupil in her most recent Diffusion article titled, “The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma.” In the article, Dr. Nastoupil discusses a study that looks at a promising therapy for the management of diffuse large B-cell lymphoma. Read more Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Apr 4, 2023
Format:
Podcast episode
Titles in the series (100)
BCL-2 Is an Effective Target in Chronic Lymphocytic Leukemia: In her Diffusion article from the May/June issue of The Hematologist, Dr. Ann LaCasce (Dana-Farber Cancer Institute) discusses the use of the recently FDA-approved drug venetoclax for the treatment of patients with chronic lymphocytic leukemia (CLL) or sm by The Hematologist